Security key
03836J102
Aprea Therapeutics, Inc. - Common Stock, par value $0.001 per share (APRE)
CUSIP: 03836J102
Q2 2021 13F Holders as of 30 Jun 2021
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 6,538,488
- Total 13F value
- $31,906,000
- Share change
- -2,395,457
- Put/Call ratio
- 175%
- SEC-reported price per share
- $4.88
- Number of holders
- 48
- Value change
- -$12,001,808
- Number of buys
- 17
- Number of sells
- 46
- Shares outstanding
- 228,836,687
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2021
Institutions
48
Top holders
10
APRE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2021
Previous quarter: Q1 2021
Aprea Therapeutics, Inc. SEC filings
Aprea Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03836J102
Recent filing periods:
Ownership snapshot
Top reported holders of APRE - Aprea Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Versant Venture Managemen...
Disclosed value leader
Versant Venture Managemen...
Comparable rows
15/15
Latest evidence
31 Mar 2021
13F
Lead comparable stake: 0.55%
Showing 1-6 of 15 holder rows.
Quick read
Versant Venture Management, LLC leads the comparable SEC ownership view at 0.55%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Versant Venture Management, LLC's linked filing trail.
Comparable ownership
Top 5
Versant Venture Management, LLC
0.55%
MORGAN STANLEY
0.44%
BlackRock Finance, Inc.
0.35%
VANGUARD GROUP INC
0.33%
Redmile Group, LLC
0.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Versant Venture Management, LLC |
13F
Company
|
0.55%
|
$6,424,000
1,259,662 shares
|
— | 31 Mar 2021 |
| MORGAN STANLEY |
13F
Company
|
0.44%
|
$5,090,000
998,127 shares
|
— | 31 Mar 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
0.35%
|
$4,135,000
810,852 shares
|
— | 31 Mar 2021 |
| VANGUARD GROUP INC |
13F
Company
|
0.33%
|
$3,839,000
752,734 shares
|
— | 31 Mar 2021 |
| Redmile Group, LLC |
13F
Company
|
0.3%
|
$3,544,000
694,918 shares
|
— | 31 Mar 2021 |
| SG Americas Securities, LLC |
13F
Company
|
0.29%
|
$3,345,000
655,888 shares
|
— | 31 Mar 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
48
Shares
6,538,488
Rows available
48
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
64
Q2 2021 holders
48
Holder diff
-16
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q2 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend